[MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE